<?xml version='1.0' encoding='utf-8'?>
<document id="29867495"><sentence text="Left Atrial Appendage Thrombus Formation in a Patient on Dabigatran Therapy Associated With ABCB1 and CES-1 Genetic Defect."><entity charOffset="57-67" id="DDI-PubMed.29867495.s1.e0" text="Dabigatran" /></sentence><sentence text="Dabigatran, directly targeting thrombin, is widely used for the prevention of stroke in nonvalvular atrial fibrillation (NVAF)"><entity charOffset="0-10" id="DDI-PubMed.29867495.s2.e0" text="Dabigatran" /></sentence><sentence text=" We reported a rare case of left atrial appendage thrombus formation in a persistent NVAF patient despite the 31 months uninterrupted treatment with dabigatran 110 mg twice daily"><entity charOffset="149-159" id="DDI-PubMed.29867495.s3.e0" text="dabigatran" /></sentence><sentence text=" The patient is a carrier of ABCB1 variant alleles with 7 heterozygote single nucleotide polymorphisms (SNPs: rs4148738, rs2235046, rs1128503, rs10276036, rs1202169, rs1202168, rs1202167) as well as CES-1 variant alleles with 2 homozygote SNPs (rs2244613 and rs4122238) and 2 heterozygote SNPs (rs8192935 and rs4580160), which may contribute to the changes of dabigatran plasma concentration"><entity charOffset="360-370" id="DDI-PubMed.29867495.s4.e0" text="dabigatran" /></sentence><sentence text=" In addition, Drug-drug interaction with atorvastatin may also play a role to decrease dabigatran plasma concentration"><entity charOffset="41-53" id="DDI-PubMed.29867495.s5.e0" text="atorvastatin" /><entity charOffset="87-97" id="DDI-PubMed.29867495.s5.e1" text="dabigatran" /><pair ddi="false" e1="DDI-PubMed.29867495.s5.e0" e2="DDI-PubMed.29867495.s5.e0" /><pair ddi="false" e1="DDI-PubMed.29867495.s5.e0" e2="DDI-PubMed.29867495.s5.e1" /></sentence><sentence text=" There are only four such cases till date, of which had thrombus in the left atrium, reported in the literature" /><sentence text=" We firstly reported the documented case in a Chinese patient carrying multiple alleles of ABCB1 and CES-1, who suffered from thrombus in the left atrial appendage despite long-term anticoagulation with dabigatran"><entity charOffset="203-213" id="DDI-PubMed.29867495.s7.e0" text="dabigatran" /></sentence><sentence text=" More clinical data are required to elucidate the impact of CES-1 and ABCB1 polymorphism on dabigatran pharmacokinetics, especially for Asian"><entity charOffset="92-102" id="DDI-PubMed.29867495.s8.e0" text="dabigatran" /></sentence><sentence text="" /></document>